Commentary: statins and fracture--why the confusion?

Edwards, C.J. and Arden, N.K. (2006) Commentary: statins and fracture--why the confusion? International Journal of Epidemiology, 35, (5), 1312-1313. (doi:10.1093/ije/dyl137).


Full text not available from this repository.

Original Publication URL:


In 1999 a paper published in Science suggested that 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) increased bone formation in rodents by effects on a potent bone forming cytokine bone morphogenetic protein-2 (BMP-2).1 Subsequent studies have suggested that statins increase bone mineral density (BMD) in humans2 and have investigated whether statin use is associated with reduced fracture risk.

Item Type: Article
Digital Object Identifier (DOI): doi:10.1093/ije/dyl137
ISSNs: 0300-5771 (print)
Related URLs:
Keywords: editorial, nosp,bone
Subjects: R Medicine
R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
Divisions : University Structure - Pre August 2011 > School of Medicine > Infection, Inflammation and Repair
ePrint ID: 61070
Accepted Date and Publication Date:
Date Deposited: 08 Sep 2008
Last Modified: 31 Mar 2016 12:44

Actions (login required)

View Item View Item